參考資料：

[1].COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. National Institutes of Health. Available at https://www.covid19treatmentguidelines.nih.gov/. Accessed [Dec 29, 2022].

[2].Siegel, M.D. Acute respiratory distress syndrome: Clinical features, diagnosis, and complications in adults. 2022 Aug 23, 2022 [cited 2022 Dec 27]; Available from: https://www.uptodate.cn/contents/acute-respiratory-distress-syndrome-clinical-features-diagnosis-and-complications-in-adults.

[3].Michalski, J.E., J.S. Kurche,D.A. Schwartz, From ARDS to pulmonary fibrosis: the next phase of the COVID-19 pandemic? Transl Res, 2022. 241: p. 13-24.

[4].Nasa, P., E. Azoulay, A.K. Khanna, R. Jain, S. Gupta, Y. Javeri, et al., Expert consensus statements for the management of COVID-19-related acute respiratory failure using a Delphi method. Crit Care, 2021. 25(1): p. 106.

[5].Hasan, S.S., T. Capstick, R. Ahmed, C.S. Kow, F. Mazhar, H.A. Merchant, et al., Mortality in COVID-19 patients with acute respiratory distress syndrome and corticosteroids use: a systematic review and meta-analysis. Expert Rev Respir Med, 2020. 14(11): p. 1149-1163.

[6].Gujski, M., M. Jankowski, D. Rabczenko, P. Gorynski,G. Juszczyk, The Prevalence of Acute Respiratory Distress Syndrome (ARDS) and Outcomes in Hospitalized Patients with COVID-19-A Study Based on Data from the Polish National Hospital Register. Viruses, 2022. 14(1).

[7].Tenforde, M.W., W.H. Self, K. Adams, M. Gaglani, A.A. Ginde, T. McNeal, et al., Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity. JAMA, 2021. 326(20): p. 2043-2054.

[8].Grapsa, E., G. Adamos, I. Andrianopoulos, V. Tsolaki, V.G. Giannakoulis, N. Karavidas, et al., Association Between Vaccination Status and Mortality Among Intubated Patients With COVID-19-Related Acute Respiratory Distress Syndrome. JAMA Netw Open, 2022. 5(10): p. e2235219.

[9].Bouzid, D., B. Visseaux, C. Kassasseya, A. Daoud, F. Femy, C. Hermand, et al., Comparison of Patients Infected With Delta Versus Omicron COVID-19 Variants Presenting to Paris Emergency Departments : A Retrospective Cohort Study. Ann Intern Med, 2022. 175(6): p. 831-837.

[10].de Prost, N., E. Audureau, N. Heming, E. Gault, T. Pham, A. Chaghouri, et al., Clinical phenotypes and outcomes associated with SARS-CoV-2 variant Omicron in critically ill French patients with COVID-19. Nat Commun, 2022. 13(1): p. 6025.

[11].European Centre for Disease Prevention and Control. Clinical characteristics of COVID-19. 2022 Aug 15, 2022 [cited 2022 Dec 28]; Available from: https://www.ecdc.europa.eu/en/covid-19/latest-evidence/clinical.

[12].Huang, C., Y. Wang, X. Li, L. Ren, J. Zhao, Y. Hu, et al., Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, 2020. 395(10223): p. 497-506.

[13].Centers for Disease Control and Prevention. Intubation or Ventilator Use in the Hospital by Week From Selected Hospitals. 2022 Jul 26, 2022 [cited 2022 Dec 27]; Available from: https://www.cdc.gov/nchs/covid19/nhcs/intubation-ventilator-use.htm.

[14].Wolrd Health Organization. Living guidance for clinical management of COVID-19. 2022 Nov 23, 2021 [cited 2022 Dec 27]; Available from: https://www.who.int/publications/i/item/WHO-2019-nCoV-clinical-2021-2.

[15].Arthur Y Kim, R.T.G. COVID-19: Management in hospitalized adults. 2022 Dec 19, 2022 [cited 2022 Dec 26]; Available from: https://www.uptodate.cn/contents/covid-19-management-in-hospitalized-adults?search=COVID%20treatment&source=search_result&selectedTitle=2~150&display_rank=2#.

[16].Hoang, A., K. Chorath, A. Moreira, M. Evans, F. Burmeister-Morton, F. Burmeister, et al., COVID-19 in 7780 pediatric patients: A systematic review. EClinicalMedicine, 2020. 24: p. 100433.

[17].Jaime G Deville, E.S., Christopher P Ouellette. COVID-19: Clinical manifestations and diagnosis in children. 2022 Nov 29, 2022 [cited 2022 Dec 28]; Available from: https://www.uptodate.cn/contents/covid-19-clinical-manifestations-and-diagnosis-in-children.